期刊文献+

奥曲肽联合奥美拉唑治疗上消化道出血的疗效 被引量:1

Curative effect by octreotide combined with omeprazole in the treatment of upper gastrointestinal hemorrhage
下载PDF
导出
摘要 目的探讨在上消化道出血中通过奥曲肽与奥美拉唑联合进行治疗的临床效果。方法 114例上消化道出血患者,根据住院顺序分为实验组和对照组,各57例。对照组患者给予奥美拉唑治疗,实验组患者在对照组基础上给予奥曲肽治疗。对比两组患者的止血情况以及再出血情况。结果实验组治疗总有效率98.25%高于对照组的85.96%,差异具有统计学意义(P<0.05)。实验组再出血率3.51%低于对照组15.79%,差异具有统计学意义(P<0.05)。结论在上消化道出血中通过奥曲肽与奥美拉唑联合进行治疗的临床效果显著,止血效果明显,并且再出血率比较低,值得在临床上推广。 Objective To investigate clinical effect by octreotide and omeprazole in combined treatment of upper gastrointestinal hemorrhage. Methods A total of 114 patients with upper gastrointestinal hemorrhage were divided by admission order into experimental group and control group, with 57 cases in each group. The control group received omeprazole for treatment, and the experimental group received additional octreotide. Comparison was made on hemostasis and rehemorrhage condition between the two groups. Results The experimental group had higher total effective rate as 98.25% than 85.96% in the control group, and the difference had statistical significance(P〈0.05). The experimental group had lower rehemorrhage rate as 3.51% than 15.79% in the control group, and the difference had statistical significance(P〈0.05). Conclusion Implement of octreotide and omeprazole in combined treatment of upper gastrointestinal hemorrhage shows precisely clinical effect, along with remarkable hemostasis effect and low rehemorrhage rate. This method is worth clinical promotion.
出处 《中国现代药物应用》 2016年第18期21-22,共2页 Chinese Journal of Modern Drug Application
关键词 奥曲肽 奥美拉唑 上消化道出血 Octreotide Omeprazole Upper gastrointestinal hemorrhage
  • 相关文献

二级参考文献53

  • 1李忍萍.肝硬化门脉高压患者上消化道出血原因分析[J].山东医药,2005,45(1):54-55. 被引量:7
  • 2徐晖,庄丽维,刘娜,刘颖,梁桃.奥曲肽、生长抑素治疗肝硬化上消化道出血疗效观察[J].中国临床医学,2006,13(6):934-935. 被引量:49
  • 3柯美云.功能性胃肠病并非单纯功能病[J].中国实用内科杂志,2009,26(4):261~262.
  • 4Nikoda V V, Bondarenko A V, Kiriushin D N, et al. Pre- vention of stress- induced damage of the upper gastrointesti- nal mucosa in patients during early postoperative period[J ]. Anesteziol Reanimatol, 2012(2) : 51.
  • 5Suk K T, Kim H S, Lee C S, et al. Clinical outcomes and risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage [ J , Clin En- dosc, 2011, 44(2): 93.
  • 6Rattanasupar A. Role of clinical parameters for predicting the cause of upper gastrointestinal bleeding [ J ]. J Med Assoc Thai, 2012, 95(1): 22.
  • 7Melinte- Popescu M, Blan G. The role of upper gastroin- testinal endoscopy in evaluation of portal hypertension [ J ]. Rev Med Chir Soc Med Nat Iasi, 2011, 115(4) : 1003.
  • 8Savi Z, Vracari V, Hadnadjev L, et al. Experience in the treatment of some complications of portal hypertension in al- coholic liver cirrhosis[J 1. Vojnosanit Pregl, 2011, 68 ( 11 ) : 917.
  • 9Gonzdlez E J, Rivera - Acosta J E, Sdnchez J M, et al. Management of upper gastrointestinal bleeding in cirrhotic pa- tients with documented esophageal varices evaluated at the Puerto Rico Medical Center[J]. Bol Asoc Med P R, 2011, 103(1): 5.
  • 10ANd S, Jafri W, Harnid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with en- doscopic band ligation: a randomized double- blind placebo- controlled trial J ]. Am J Gastroenterol, 2009, 104 ( 3 ) : 617.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部